Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases

Contraception

Volumn 73, Issue 5, 2006, Pages 516-519

  Goh, Sin Ee ^a   Thong, Kok Joo ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Labour induction abortion; Mifepristone; Misoprostol; Second trimester

Indexed keywords

ANALGESIC AGENT; ANTIEMETIC AGENT; CODEINE PHOSPHATE; CYCLIZINE; DIAMORPHINE; MIFEPRISTONE; MISOPROSTOL;

ADOLESCENT; ADULT; ANALGESIA; ARTICLE; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DIARRHEA; DRUG EFFECT; DRUG SAFETY; FEMALE; GESTATION PERIOD; HUMAN; INDUCED ABORTION; MAJOR CLINICAL STUDY; MULTIPARA; NULLIPARA; OVERALL SURVIVAL; PAIN; PREGNANCY TERMINATION; SCHOOL CHILD; SECOND TRIMESTER ABORTION; UTERUS; VOMITING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; FEMALE; HUMANS; MIFEPRISTONE; MISOPROSTOL; PREGNANCY; PREGNANCY TRIMESTER, SECOND; RETROSPECTIVE STUDIES;

EID: 33646481992     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2005.12.004     Document Type: Article

References (15)

1. 2α. Lancet (1970) 157-159
2. Thong K.J., and Baird D.T. Induction of second trimester abortion with mifepristone and gemeprost. Br J Obstet Gynaecol 100 (1993) 758-761
3. Ashok P.W., and Templeton A. Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases. Br J Obstet Gynaecol 106 (1999) 706-710
4. Gemzell-Danielsson K., and Ostlund E. Termination of second trimester pregnancy with mifepristone and gemeprost. The clinical experience of 197 cases. Acta Obstet Gynaecol Scand 79 (2000) 702-706
5. El-Refaey H., Hinshaw K., and Templeton A. The abortifacient effect of misoprostol in the second trimester. Hum Reprod 8 (1993) 1744-1746
6. El-Refaey H., and Templeton A. Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens. Hum Reprod 10 (1995) 475-478
7. Collins P.W. Misoprostol: discovery, development, and clinical applications. Med Res Rev 10 (1990) 149-172
8. McKinley C., Thong K.J., and Baird D.T. The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol. Hum Reprod 8 (1993) 1502-1505
9. Urquhart D.R., and Templeton A. The use of mifepristone prior to prostaglandin induced mid-trimester termination. Hum Reprod 5 (1990) 883-886
10. Rodger M.T., and Baird D.T. Pre-treatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion. Br J Obstet Gynaecol 97 (1990) 41-45
11. Webster D., Penney G.C., and Templeton A. A comparison of 600 and 200 mg mifepristone prior to second trimester abortion with prostaglandin misoprostol. Br J Obstet Gynaecol 103 (1996) 706-709
12. Thong K.J., and Baird D.T. Induction of abortion with mifepristone and misoprostol in early pregnancy. Br J Obstet Gynaecol 99 (1992) 1004-1007
13. Tang O.S., Thong K.J., and Baird D.T. Second trimester medical abortion with mifepristone and gemeprost: a review of 956 cases. Contraception 64 (2001) 29-32
14. Bartley J., Tong S., Everington D., and Baird D.T. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception 62 (2000) 297-303
15. Ashok P.W., Penney G.C., Flett G.M.M., and Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod 13 (1998) 2962-2965